Home
Browse
Search
Statistics
About
Usage
PMID: 16417523
Loo TW, Bartlett MC, Wang Y, Clarke DM
The chemical chaperone CFcor-325 repairs folding defects in the transmembrane domains of CFTR-processing mutants.
Biochem J. 2006 May 1;395(3):537-42., 2006-05-01
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
4
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:4:119
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:4:108
status:
NEW
view ABCC7 p.Gln1071Pro details
To test if CFcor-325 promoted correct folding of the TMDs (TM domains), we selected two of the CL4 mutants (
Q1071P
and
H1085R
) for disulphide cross-linking analysis.
Login to comment
5
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:5:115
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:5:104
status:
NEW
view ABCC7 p.Gln1071Pro details
Pairs of cysteine residues that were cross-linked in mature wild-type CFTR were introduced into mutants
Q1071P
and
H1085R
.
Login to comment
6
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:6:44
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:6:34
status:
NEW
view ABCC7 p.Gln1071Pro details
The cross-linking patterns of the
Q1071P
or
H1085R
double cysteine mutants rescued with CFcor-325 were similar to those observed with mature wild-type double cysteine proteins.
Login to comment
21
ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 16417523:21:108
status:
NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:21:140
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 16417523:21:132
status:
NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 16417523:21:116
status:
NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Trp1098Arg
X
ABCC7 p.Trp1098Arg 16417523:21:151
status:
NEW
view ABCC7 p.Trp1098Arg details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 16417523:21:92
status:
NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Gly1061Arg
X
ABCC7 p.Gly1061Arg 16417523:21:100
status:
NEW
view ABCC7 p.Gly1061Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:21:124
status:
NEW
view ABCC7 p.Gln1071Pro details
EXPERIMENTAL Construction and expression of mutants The cDNAs of wild-type and CL4 mutants (
H1054D
,
G1061R
,
L1065P
,
R1066H
,
Q1071P
,
L1077P
,
H1085R
and
W1098R
) were inserted into pcDNA3 vector (Invitrogen, Oakville, ON, Canada) as described previously [2].
Login to comment
22
ABCC7 p.Thr351Cys
X
ABCC7 p.Thr351Cys 16417523:22:70
status:
NEW
view ABCC7 p.Thr351Cys details
Construction of CFTR double cysteine mutants M348C(TM6)/T1142C(TM12),
T351C
- (TM6)/T1142C(TM12) and W356C(TM6)/W1145C(TM12) was described previously [10].
Login to comment
23
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:23:62
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:23:52
status:
NEW
view ABCC7 p.Gln1071Pro details
Site-directed mutagenesis was used to introduce the
Q1071P
or
H1085R
mutations into the double cysteine mutants as described previously [11].
Login to comment
31
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:31:201
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Thr1142Cys
X
ABCC7 p.Thr1142Cys 16417523:31:82
status:
NEW
view ABCC7 p.Thr1142Cys details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:31:184
status:
NEW
view ABCC7 p.Gln1071Pro details
Disulphide cross-linking analysis The cDNAs of double cysteine mutants M348C(TM6)/
T1142C
- (TM12), T351C(TM6)/T1142C(TM12) and W356C(TM6)/ W1145C(TM12) constructed in wild-type, mutant
Q1071P
or mutant
H1085R
backgrounds were expressed in HEK-293 cells in the presence or absence of 3 µM CFcor-325.
Login to comment
37
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:37:54
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:37:44
status:
NEW
view ABCC7 p.Gln1071Pro details
Briefly, cells expressing wild-type, mutant
Q1071P
or
H1085R
CFTR were grown with or without 3 µM CFcor-325.
Login to comment
51
ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 16417523:51:73
status:
NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:51:105
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 16417523:51:97
status:
NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 16417523:51:81
status:
NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Trp1098Arg
X
ABCC7 p.Trp1098Arg 16417523:51:115
status:
NEW
view ABCC7 p.Trp1098Arg details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 16417523:51:57
status:
NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Gly1061Arg
X
ABCC7 p.Gly1061Arg 16417523:51:65
status:
NEW
view ABCC7 p.Gly1061Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:51:89
status:
NEW
view ABCC7 p.Gln1071Pro details
Accordingly, HEK-293 cells were transfected with mutants
H1054D
,
G1061R
,
L1065P
,
R1066H
,
Q1071P
,
L1077P
,
H1085R
or
W1098R
cDNAs.
Login to comment
55
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 16417523:55:86
status:
NEW
view ABCC7 p.Arg1066His details
In contrast, the amount of mature protein in all the processing mutants except mutant
R1066H
was less than 5% (Figure 2B).
Login to comment
56
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 16417523:56:36
status:
NEW
view ABCC7 p.Arg1066His details
The amount of mature CFTR in mutant
R1066H
was 10%.
Login to comment
57
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:57:62
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 16417523:57:54
status:
NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 16417523:57:38
status:
NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Trp1098Arg
X
ABCC7 p.Trp1098Arg 16417523:57:73
status:
NEW
view ABCC7 p.Trp1098Arg details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 16417523:57:22
status:
NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Gly1061Arg
X
ABCC7 p.Gly1061Arg 16417523:57:30
status:
NEW
view ABCC7 p.Gly1061Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:57:46
status:
NEW
view ABCC7 p.Gln1071Pro details
Expression of mutants
H1054D
,
G1061R
,
R1066H
,
Q1071P
,
L1077P
,
H1085R
and
W1098R
in the presence of 3 µM CFcor-325, however, induced expression of the 190 kDa mature protein.
Login to comment
59
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:59:72
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 16417523:59:56
status:
NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Trp1098Arg
X
ABCC7 p.Trp1098Arg 16417523:59:83
status:
NEW
view ABCC7 p.Trp1098Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:59:64
status:
NEW
view ABCC7 p.Gln1071Pro details
The chemical chaperone most efficiently rescued mutants
R1066H
,
Q1071P
,
H1085R
and
W1098R
as the amount of mature CFTR was approx.
Login to comment
61
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 16417523:61:69
status:
NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 16417523:61:50
status:
NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Gly1061Arg
X
ABCC7 p.Gly1061Arg 16417523:61:58
status:
NEW
view ABCC7 p.Gly1061Arg details
Lower levels of rescue were observed with mutants
H1054D
,
G1061R
and
L1077P
(5-15% mature CFTR protein).
Login to comment
62
ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 16417523:62:7
status:
NEW
view ABCC7 p.Leu1065Pro details
Mutant
L1065P
was the only mutant that could not be rescued with CFcor-325 (Figure 2B).
Login to comment
73
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:73:28
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:73:17
status:
NEW
view ABCC7 p.Gln1071Pro details
Two CL4 mutants,
Q1071P
and
H1085R
, were selected for cross-linking analysis because they were efficiently rescued with CFcor-325.
Login to comment
74
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:74:32
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:74:22
status:
NEW
view ABCC7 p.Gln1071Pro details
Expression of mutants
Q1071P
or
H1085R
in the presence of CFcor-325 increased the amount of mature CFTR from less than 5% (in the absence of corrector) of total to more than 30% (Figures 2A and 2B).
Login to comment
77
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:77:182
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:77:165
status:
NEW
view ABCC7 p.Gln1071Pro details
Mature 190 kDa CFTR, however, contains complex carbohydrate groups that are resistant to endo H but not to PNGase F. Accordingly, cells expressing wild-type, mutant
Q1071P
or mutant
H1085R
CFTR and grown in the presence or absence of CFcor-325 were extracted with SDS and then treated with endoglycosidases.
Login to comment
78
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:78:118
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:78:101
status:
NEW
view ABCC7 p.Gln1071Pro details
Figure 3 shows that the 170 kDa immature CFTRs but not the 190 kDa mature CFTRs of wild-type, mutant
Q1071P
or mutant
H1085R
were sensitive to digestion with endo H.
Login to comment
79
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:79:136
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:79:125
status:
NEW
view ABCC7 p.Gln1071Pro details
Both the 190 kDa mature and 170 kDa immature CFTRs were sensitive to digestion with PNGase F. Therefore expression of mutant
Q1071P
and
H1085R
in the presence of CFcor-325 promoted maturation and trafficking of the proteins from the ER to the Golgi where complex carbohydrates are added to the protein.
Login to comment
81
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:81:52
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:81:35
status:
NEW
view ABCC7 p.Gln1071Pro details
Cells expressing wild-type, mutant
Q1071P
or mutant
H1085R
CFTRs were grown in the presence or absence of 3 µM CFcor-325.
Login to comment
82
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:82:132
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:82:115
status:
NEW
view ABCC7 p.Gln1071Pro details
The cells Figure 3 Endoglycosidase digestion Whole cell SDS extracts of HEK-293 cells expressing wild-type, mutant
Q1071P
or mutant
H1085R
in the absence (-) or presence (+) of 3 µM CFcor-325 were treated with endo H (H), PNGase F (F) or no endoglycosidase (-).
Login to comment
85
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:85:142
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:85:125
status:
NEW
view ABCC7 p.Gln1071Pro details
Figure 4 Cell surface labelling of CFTR (A) BHK cells (Control) or BHK cells stably expressing wild-type (Wild-type), mutant
Q1071P
or mutant
H1085R
CFTRs were grown in the presence (+) or absence (-) of 3 µM CFcor-325.
Login to comment
93
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:93:181
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:93:164
status:
NEW
view ABCC7 p.Gln1071Pro details
Figure 4(A) Figure 5 Measurement of cAMP-stimulated iodide efflux activities Iodide efflux assays were performed on BHK cells stably expressing wild-type, mutant
Q1071P
or mutant
H1085R
CFTRs that were grown in the presence (+CFcor-325) or absence (untreated) of CFcor-325 as described in the Experimental section.
Login to comment
94
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:94:23
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:94:84
status:
NEW
view ABCC7 p.Gln1071Pro details
The activity of mutant
H1085R
grown without CFcor-325 was similar to that of mutant
Q1071P
(untreated) and is omitted for clarity.
Login to comment
97
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:97:85
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:97:74
status:
NEW
view ABCC7 p.Gln1071Pro details
Similarly, labelled mature 190 kDa CFTR proteins were detected in mutants
Q1071P
and
H1085R
only after rescue with CFcor-325.
Login to comment
98
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:98:121
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:98:110
status:
NEW
view ABCC7 p.Gln1071Pro details
Figure 4(B) shows that there was good correlation between the amount of biotinylated CFTR proteins in mutants
Q1071P
and
H1085R
with the amount of mature CFTRs detected in Figure 2(B) (63 and 50% of wild-type respectively).
Login to comment
99
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:99:41
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:99:31
status:
NEW
view ABCC7 p.Gln1071Pro details
Next, we tested whether mutant
Q1071P
or
H1085R
was active at the cell surface after rescue with CFcor-325.
Login to comment
100
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:100:19
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:100:8
status:
NEW
view ABCC7 p.Gln1071Pro details
Mutants
Q1071P
and
H1085R
CFTRs were stably expressed in BHK cells because adherent cells are essential for the iodide efflux assays.
Login to comment
102
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:102:50
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:102:40
status:
NEW
view ABCC7 p.Gln1071Pro details
The BHK cells stably expressing mutants
Q1071P
or
H1085R
were treated for 48 h with or without 3 µM CFcor-325 and then used in iodide efflux assays.
Login to comment
106
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:106:64
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:106:54
status:
NEW
view ABCC7 p.Gln1071Pro details
In contrast, BHK cells stably expressing CFTR mutants
Q1071P
or
H1085R
demonstrated iodide efflux activity only when grown in the presence of CFcor-325 (Figure 5).
Login to comment
108
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:108:18
status:
NEW
view ABCC7 p.Gln1071Pro details
Therefore mutants
Q1071P
and h1085R were used for cross-linking studies.
Login to comment
109
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:109:133
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:109:123
status:
NEW
view ABCC7 p.Gln1071Pro details
Accordingly, M348C(TM6)/T1142C(TM12), T351C(TM6)/ T1142C(TM12) or W356C(TM6)/W1145C(TM12) mutations were introduced into a
Q1071P
or
H1085R
CFTR background.
Login to comment
110
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:110:18
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Thr1142Cys
X
ABCC7 p.Thr1142Cys 16417523:110:47
status:
NEW
view ABCC7 p.Thr1142Cys details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:110:8
status:
NEW
view ABCC7 p.Gln1071Pro details
Mutants
Q1071P
or
H1085R
containing M348C(TM6)/
T1142C
- (TM12), T351C(TM6)/T1142C(TM12) or W356C(TM6)/ W1145C(TM12) mutations were then transiently expressed in HEK-293 cells in the presence or absence of 3 µM CFcor-325 for 48 h and then treated with the homobifunctional cross-linkers M5M, M8M or M17M.
Login to comment
115
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:115:292
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:115:325
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:115:360
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:115:435
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Thr351Cys
X
ABCC7 p.Thr351Cys 16417523:115:218
status:
NEW
view ABCC7 p.Thr351Cys details
ABCC7 p.Trp356Cys
X
ABCC7 p.Trp356Cys 16417523:115:367
status:
NEW
view ABCC7 p.Trp356Cys details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:115:14
status:
NEW
view ABCC7 p.Gln1071Pro details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:115:179
status:
NEW
view ABCC7 p.Gln1071Pro details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:115:211
status:
NEW
view ABCC7 p.Gln1071Pro details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:115:248
status:
NEW
view ABCC7 p.Gln1071Pro details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:115:418
status:
NEW
view ABCC7 p.Gln1071Pro details
Mature mutant
Q1071P
/ M348C(TM6)/T1142C(TM12) protein was cross-linked with Figure 6 Disulphide cross-linking analysis of CFTR processing mutants HEK-293 cells expressing mutants
Q1071P
/M348C(TM6)/T1142C(TM12),
Q1071P
/
T351C
- (TM6)/T1142C(TM12) and
Q1071P
/W356C(TM6)/W1145C(TM12) (A), mutants
H1085R
/ M348C(TM6)/T1142C(TM12),
H1085R
/T351C(TM6)/T1142C(TM12) and
H1085R
/
W356C
- (TM6)/W1145C(TM12) (B) or wild-type, mutant
Q1071P
or mutant
H1085R
(C) were incubated for 48 h with (+) or without (-) 3 µM CFcor-325.
Login to comment
119
ABCC7 p.Thr351Cys
X
ABCC7 p.Thr351Cys 16417523:119:21
status:
NEW
view ABCC7 p.Thr351Cys details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:119:14
status:
NEW
view ABCC7 p.Gln1071Pro details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:119:139
status:
NEW
view ABCC7 p.Gln1071Pro details
Mature mutant
Q1071P
/
T351C
- (TM6)/T1142C(TM12) protein was cross-linked with M8M and to a lesser extent with M17M, while the mature mutant
Q1071P
/W356C(TM6)/W1145C(TM12) protein was cross-linked with M5M, M8M and M17M (Figure 6A).
Login to comment
120
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:120:39
status:
NEW
view ABCC7 p.His1085Arg details
Similar results were observed with the
H1085R
double cysteine mutants (Figure 6B).
Login to comment
122
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:122:48
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:122:38
status:
NEW
view ABCC7 p.Gln1071Pro details
In contrast, wild-type, mature mutant
Q1071P
or
H1085R
CFTRs lacking the introduced cysteine residues was not cross-linked by M5M, M8M or M17M (Figure 6C).
Login to comment
123
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:123:149
status:
NEW
view ABCC7 p.Gln1071Pro details
The immature 170 kDa mutant proteins did not 7 Effect of dithiothreitol on immature CFTR treated with cross-linker HEK-293 cells expressing mutant
Q1071P
/M348C(TM6)/T1142C(TM12) in the absence of CFcor-325 were treated with 0.2 mM M5M, M8M or M17M cross-linker for 15 min at 20◦C. Samples were then incubated with (+DTT) or without (-DTT) 30 mM dithiothreitol for 5 min at 20◦C. Following SDS/PAGE on a 5.5% gel, the stacking and separating gels were transferred on to a sheet of nitrocellulose and CFTR protein was detected by immunoblot analysis.
Login to comment
126
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:126:46
status:
NEW
view ABCC7 p.Gln1071Pro details
An example of aggregation is shown for mutant
Q1071P
/M348C(TM6)/ T1142C(TM12) (Figure 7).
Login to comment
129
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 16417523:129:42
status:
NEW
view ABCC7 p.His1085Arg details
Similar results were observed with mutant
H1085R
/M348C(TM6)/T1142(TM12) (results not shown).
Login to comment
144
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:144:24
status:
NEW
view ABCC7 p.Gln1071Pro details
The processing mutation
Q1071P
traps the protein in the ER in a loosely folded conformation because of altered TM packing (B).
Login to comment
152
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 16417523:152:46
status:
NEW
view ABCC7 p.Gln1071Pro details
The presence of a processing mutation such as
Q1071P
introduces a thermodynamic hurdle during folding so that the protein is trapped in an immature conformation (Figure 8B).
Login to comment